TARGETING IMMUNOTHERAPY-RESISTANT LESIONS TO ERADICATE OLIGOMETASTATIC PROSTATE CANCER

$516,366FY2024Defense Health AgencyDOD

University Of Wisconsin System, Madison WI

Investigators